XML 58 R49.htm IDEA: XBRL DOCUMENT
v2.4.1.9

OPERATING SEGMENT AND GEOGRAPHIC INFORMATION (Details) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2015 operating_segments | Mar. 31, 2014 | Dec. 31, 2014
Segment Reporting [Abstract] |  |  |
Number of operating segments | 2 us-gaap_NumberOfOperatingSegments |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | $ 6,513 us-gaap_SalesRevenueNet | $ 6,251 us-gaap_SalesRevenueNet |
Gross Profit | 2,974 us-gaap_GrossProfit | 2,494 us-gaap_GrossProfit |
Net Loss before Taxes | (2,995)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | (3,671)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest |
Income Tax Expense | 46 us-gaap_IncomeTaxExpenseBenefit | 505 us-gaap_IncomeTaxExpenseBenefit |
NET LOSS | (3,041)us-gaap_NetIncomeLoss | (4,176)us-gaap_NetIncomeLoss | (13,942)us-gaap_NetIncomeLoss
Depreciation/Amortization | 553 us-gaap_DepreciationDepletionAndAmortization | 493 us-gaap_DepreciationDepletionAndAmortization |
Interest Expense, net | 190 us-gaap_InterestIncomeExpenseNet | 182 us-gaap_InterestIncomeExpenseNet |
Total Assets | 34,491 us-gaap_Assets | 30,717 us-gaap_Assets | 30,006 us-gaap_Assets
Maximum |  |  |
Segment Reporting Information [Line Items] |  |  |
Percent of revenue from countries not separately disclosed (more than) | 5.00%tbio_PercentOfRevenueFromCountriesNotSeparatelyDisclosed / us-gaap_RangeAxis = us-gaap_MaximumMember |  |
United States |  |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | 5,509 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_US | 4,763 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_US |
United States | Minimum |  |  |
Segment Reporting Information [Line Items] |  |  |
Long-lived asset percentage held in a specific location | 99.00%tbio_LongLivedAssetPercentageHeldInSpecificLocation / us-gaap_RangeAxis = us-gaap_MinimumMember / us-gaap_StatementGeographicalAxis = country_US |  |
Italy |  |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | 177 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_IT | 385 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = country_IT |
All Other Countries |  |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | 827 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = tbio_AllOtherCountriesMember | 1,103 us-gaap_SalesRevenueNet / us-gaap_StatementGeographicalAxis = tbio_AllOtherCountriesMember |
Laboratory Services |  |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | 4,871 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 3,688 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Gross Profit | 2,696 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 1,632 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Net Loss before Taxes | (2,110)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (2,984)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Income Tax Expense | 41 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 509 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
NET LOSS | (2,151)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | (3,493)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Depreciation/Amortization | 507 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 440 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Interest Expense, net | 142 us-gaap_InterestIncomeExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 107 us-gaap_InterestIncomeExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Total Assets | 27,563 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember | 22,446 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_ClinicalLaboratoriesMember |
Genetic Assays and Platforms |  |  |
Segment Reporting Information [Line Items] |  |  |
Net Sales | 1,642 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 2,563 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Gross Profit | 278 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 862 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Net Loss before Taxes | (885)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (687)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Income Tax Expense | 5 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (4)us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
NET LOSS | (890)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | (683)us-gaap_NetIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Depreciation/Amortization | 46 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 53 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Interest Expense, net | 48 us-gaap_InterestIncomeExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | 75 us-gaap_InterestIncomeExpenseNet / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |
Total Assets | $ 6,928 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember | $ 8,271 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = tbio_GeneticAssaysandPlatformsMember |

X
- Definition Long-lived asset percentage held in a specific location + References No definition available. + Details
Name: | tbio_LongLivedAssetPercentageHeldInSpecificLocation
Namespace Prefix: | tbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percent Of Revenue From Countries Not Separately Disclosed + References No definition available. + Details
Name: | tbio_PercentOfRevenueFromCountriesNotSeparatelyDisclosed
Namespace Prefix: | tbio_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 5 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net amount of operating interest income (expense). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 + Details
Name: | us-gaap_InterestIncomeExpenseNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tbio_ClinicalLaboratoriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tbio_GeneticAssaysandPlatformsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_IT
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=tbio_AllOtherCountriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |